YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

AstraZeneca enters $6B oncology deal

Posted online

AstraZeneca entered into an oncology collaboration with Daiichi Sankyo Co. that's worth up to $6 billion.

MarketWatch reports the deal could redefine treatment standards in lung, breast and multiple other cancers.

AstraZeneca initially will pay Daiichi Sankyo $1 billion.

Read more from MarketWatch.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Letter to the Editor: No half-baked cake for our kids. No half-baked school grades, either.

Nixa Superintendent Gearl Loden weighs in on A-F grade cards.

Most Read
Update cookies preferences